Azienda Opsedaliera S. Maria di Terni

Terni 05100

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration Resistant Prostate Cancer

Studies at this site

• A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
• A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed